Los Angeles Holds No. 1 Spot on Orkin's 2026 Rattiest Cities List

Orkin’s 2026 Rattiest Cities List keeps Los Angeles at No. 1, followed by Chicago and New York City; the top four cities were unchanged year over year. Albuquerque climbed 12 places to No. 31, while Nashville and Albany each rose 10 places; rankings reflect new residential rodent treatments from Aug. 9, 2025, to Aug. 9, 2026.

Analysis

The ranking is a weak demand indicator, not evidence of a step-change in Rollins’ earnings: it counts new residential treatments over a year, gives no absolute treatment volumes, and reflects Orkin’s own customer activity rather than citywide infestation rates. The promotional context also favors caution. More relevant to ROL is whether rodent calls convert into recurring plans or higher-value exclusion work; that could support revenue per customer, but technician time, travel density, and service costs determine whether it lifts margins. A broad, geographically dispersed list may be more useful as a reminder that demand is not confined to one climate than as a basis for reallocating exposure by city. Near term, seasonal indoor activity could support lead flow, but the article does not establish incremental bookings or pricing. Over 1–3 months, verify residential pest organic growth, customer retention, pricing versus volume, and labor productivity in Rollins’ results. Over 6–18 months, persistent demand matters only if it translates into recurring revenue and sound route economics. Contrarian read: the apparent breadth of rodent pressure is already a marketing narrative, while the ranking’s movement may mostly reflect treatment-count variability. No material valuation signal or trade is justified from this release alone.

Key Decisions for Investors

• No trade on the ranking itself; treat it as a low-confidence demand watch item, not a forward earnings revision for ROL.
• At the next results, check residential pest organic growth, retention, pricing versus volume, and labor productivity; stronger recurring growth without margin deterioration would be the evidence needed to revisit a constructive ROL view.
• Do not infer that cities climbing the list have the largest addressable revenue opportunity: the release omits city-level treatment counts, market share, and service economics.
• Falsify the modestly constructive seasonal-demand hypothesis if residential pest growth weakens or labor/service costs pressure margins despite higher reported rodent activity.